VascuSense
Non-invasive technology addressing chronic total occlusion and critical limb ischemia through innovative treatments.
Non-invasive technology addressing chronic total occlusion and critical limb ischemia through innovative treatments.
VascuSense, a non-invasive technology startup, is focused on addressing chronic total occlusion and critical limb ischemia through innovative treatments. The company's slogan, "Non-invasive technology addressing chronic total occlusion and critical limb ischemia through innovative treatments," succinctly captures its mission. VascuSense's technology is designed to treat patients with chronic total occlusion, specifically targeting full blockages of coronary arteries that lead to critical limb ischemia. As a player in the Health Care industry, VascuSense received a grant investment on 15 November 2022 from the Department of Enterprise, Trade and Employment. This backing reflects a strong vote of confidence in the potential of VascuSense's innovative approach to addressing critical medical conditions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | Unknown | 1 |
|
15 Nov 2022 |
No recent news or press coverage available for VascuSense.
We care about your data, and we'd love to use cookies make your experience better.
